K+S Aktiengesellschaft (OTCMKTS:KPLUF) Sees Significant Drop in Short Interest
by Renee Jackson · The Cerbat GemK+S Aktiengesellschaft (OTCMKTS:KPLUF – Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 15th, there was short interest totaling 373,812 shares, a decline of 52.8% from the September 30th total of 792,101 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.
K+S Aktiengesellschaft Stock Performance
Shares of KPLUF remained flat at $14.61 on Friday. The stock has a 50 day moving average price of $18.72 and a two-hundred day moving average price of $17.66. K+S Aktiengesellschaft has a 12 month low of $13.16 and a 12 month high of $21.20.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on KPLUF shares. DZ Bank raised K+S Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 13th. Scotiabank raised K+S Aktiengesellschaft from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 7th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy”.
Check Out Our Latest Report on KPLUF
About K+S Aktiengesellschaft
K+S Aktiengesellschaft is a Germany-based producer of mineral products, with its principal activities focused on fertilizers and salt. The company supplies potash and magnesium products used in agriculture, including fertilizers designed to support crop nutrition and improve soil management.
K+S also produces and markets a broad range of salt products. These include de-icing salt for roads, industrial salt for manufacturing processes, food-grade salt, and salt for water treatment and other consumer applications.
Featured Articles
- Five stocks we like better than K+S Aktiengesellschaft
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?